3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
3
Vaginal Neoplasms
2
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neuroendocrine Tumors
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Accelerated Phase
1
Gallbladder Neoplasms
1
Blast Crisis
1
Interventions
Cytarabine
7
Daunorubicin
3
Mitoxantrone
2
Idarubicin
2
Gemtuzumab
2
Etoposide
2
Clofarabine
2
tipifarnib
1
temsirolimus
1
midostaurin
1
etoposide phosphate
1
eltrombopag
1
dexamethasone acetate
1
alvocidib
1
aldesleukin
1
Whole-Body Irradiation
1
Proto-Oncogene Proteins c-kit
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
Observation
1
Lenalidomide
1
Imatinib Mesylate
1
Gene Expression Profiling
1
Flow Cytometry
1
Filgrastim
1
Busulfan
1
Bone Marrow Transplantation
1
Biopsy
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Basophilic, Acute
×
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
×
Clear all
No trials found.